These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4036972)

  • 1. Cost savings associated with use of gentamicin versus tobramycin.
    Schwinghammer TL; Romano MJ; Wing EJ
    Am J Hosp Pharm; 1985 Aug; 42(8):1745-9. PubMed ID: 4036972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective audit of an aminoglycoside consultative service in a general hospital.
    Li SC; Ioannides-Demos LL; Spicer WJ; Spelman DW; Tong N; McLean AJ
    Med J Aust; 1992 Sep; 157(5):308-11. PubMed ID: 1435470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-benefit analysis of an aminoglycoside monitoring service.
    Kimelblatt BJ; Bradbury K; Chodoff L; Aggour T; Mehl B
    Am J Hosp Pharm; 1986 May; 43(5):1205-9. PubMed ID: 3087162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of pharmacy intervention on aminoglycoside costs.
    Tsuyuki RT; Nakagawa RS
    Can J Hosp Pharm; 1987 Apr; 40(2):51-6. PubMed ID: 10282090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost-effectiveness of clinical pharmacist intervention on tobramycin prescribing.
    Khanderia U
    Hosp Formul; 1986 Oct; 21(10):1049-50, 1055-6. PubMed ID: 10311722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical considerations and costs associated with formulary conversion from tobramycin to gentamicin.
    Green ER; Chrymko MM; Rozek SL; Kitrenos JG
    Am J Hosp Pharm; 1989 Apr; 46(4):714-9. PubMed ID: 2719049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of aminoglycoside-use restrictions on drug cost.
    DeTorres OH; White RE
    Am J Hosp Pharm; 1984 Jun; 41(6):1137-9. PubMed ID: 6430070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Financial impact of an aminoglycoside substitution program.
    Andrews JD; Stad K
    Can J Hosp Pharm; 1987 Feb; 40(1):23-6. PubMed ID: 10281256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacist interventions to improve prescribing of vancomycin and tobramycin.
    Fletcher CV; Giese RM; Rodman JH
    Am J Hosp Pharm; 1986 Sep; 43(9):2198-201. PubMed ID: 3766572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoglycoside use monitored by clinical pharmaceutical services.
    Barriere SL; Conte JE
    Am J Hosp Pharm; 1979 Sep; 36(9):1209-11. PubMed ID: 495621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A practical approach enabling staff pharmacists to prospectively review and dose aminoglycoside therapy.
    Possidente CJ; Lynch T
    Hosp Pharm; 1988 Nov; 23(11):976-8, 981-3. PubMed ID: 10290757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Providing guidelines and education is not enough: an audit of gentamicin use at The Royal Melbourne Hospital.
    Leong CL; Buising K; Richards M; Robertson M; Street A
    Intern Med J; 2006 Jan; 36(1):37-42. PubMed ID: 16409311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost containment through therapeutic substitution of aminoglycosides.
    Guernsey BG; Berina LF; Lazarus MC; Hokanson JA; Prohaska C; Allen JA; Doutre WH; Mader JT
    Hosp Pharm; 1985 Feb; 20(2):82-3, 86-92, 95. PubMed ID: 10270312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions.
    Hayman JN; Sbravati EC
    Am J Hosp Pharm; 1985 Jun; 42(6):1343-7. PubMed ID: 4014250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gentamicin and tobramycin pharmacokinetics in patients with cystic fibrosis.
    Bauer LA; Piecoro JJ; Wilson HD; Blouin RA
    Clin Pharm; 1983; 2(3):262-4. PubMed ID: 6883955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost analysis of mixing clindamycin and aminoglycosides.
    Abel SR; Olson SM
    Am J Hosp Pharm; 1987 Jun; 44(6):1385-7. PubMed ID: 3618617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suboptimal aminoglycoside dosing in critically ill patients.
    Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
    Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative cost effectiveness of gentamicin and tobramycin.
    Holloway JJ; Smith CR; Moore RD; Feroli ER; Lietman PS
    Ann Intern Med; 1984 Dec; 101(6):764-9. PubMed ID: 6437310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoeconomics of aztreonam-clindamycin versus gentamicin-clindamycin in the treatment of penetrating abdominal injury.
    Fabian TC; Boucher BA; Croce MC
    Pharmacotherapy; 1996; 16(5):951-7. PubMed ID: 8888092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of gentamicin premixed admixtures: cost and clinical utility.
    Zarowitz BJ; Owen H; Popovich J; Pancorbo S
    Hosp Pharm; 1987 Mar; 22(3):257-60. PubMed ID: 10311980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.